Abstract
Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Current Bioactive Compounds
Title: The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate
Volume: 6 Issue: 3
Author(s): Jean Fotie
Affiliation:
Keywords: Ellagic acid and derivatives, synthesis, antimalarial activity, other biological and pharmacological properties
Abstract: Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables including raspberries, strawberries, cranberries, walnuts, pecans, pomegranates and other plant foods. The antiproliferative and antioxidant properties of ellagic acid have spurred several researches into the potential health benefits of its consumption, leading to its marketing as a dietary supplement. Recently, ellagic acid was shown to display interesting and usable antimalarial activity. However, the relatively insolubility of this compound in water and organic solvents, and its low bioavailability tend to disqualify it as a potential drug candidate. In this review, we will discuss the potential of ellagic acid and derivatives as antimalarial drug candidates. While highlighting their numerous biological and pharmacological activities against other human ailments, we will evaluate the possibility of developing this family of compounds as antimalarial drugs, and discuss strategies and related challenges to achieve that goal.
Export Options
About this article
Cite this article as:
Fotie Jean, The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate, Current Bioactive Compounds 2010; 6 (3) . https://dx.doi.org/10.2174/157340710793237344
DOI https://dx.doi.org/10.2174/157340710793237344 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential.
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Medicinal Chemistry Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review
Current Medicinal Chemistry Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design The Chemical Defensive System in the Pathobiology of Idiopathic Environment- Associated Diseases
Current Drug Metabolism The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design The Role of Vitamin D and Sunlight Incidence in Cancer
Anti-Cancer Agents in Medicinal Chemistry Intracellular Trafficking Mechanism and Cytosolic Protein Interactions of a Non Viral Gene Delivery Vector: Studies Based on Transferrin Conjugated Pullulan-PEI
Current Nanoscience Ascorbic Acid in Cancer Chemoprevention: Translational Perspectives and Efficacy
Current Drug Targets Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Current Strategy for Cisplatin Delivery
Current Cancer Drug Targets Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer
Clinical Cancer Drugs Therapeutic Applications of Crocus sativus L. (Saffron): A Review
The Natural Products Journal Oxidative DNA Damage and Oxidant/Anti-Oxidant Enzymatic Systems in Carcinogenesis and Cancer Progression
Current Enzyme Inhibition